US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Maison Solutions

0.3720

-0.0580-13.49%

Post-market: 0.39990.0279+7.50%15:38 EST

Volume:197.95K

Turnover:78.64K

Market Cap:9.39M

PE:-5.88

High:0.4210

Open:0.4200

Low:0.3700

Close:0.4300

52wk High:3.96

52wk Low:0.3020

Shares:25.23M

Float Shares:8.63M

Volume Ratio:0.09

T/O Rate:2.29%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0633

EPS(LYR):0.0670

ROE:-9.15%

ROA:-2.53%

PB:0.93

PE(LYR):5.55

Loading ...

Overview Company News Filings

Maison Solutions Q2 EPS $(0.23) Down From $(0.01) YoY, Sales $27.625M Miss $29.500M Estimate

BRIEF-Maison Solutions Inc Enters Consent And Waiver With Investor

Maison Solutions Inc - Enters Consent and Waiver With Investor - SEC Filing

THOMSON REUTERS

Maison Solutions: Under Agreement, Some Restrictive Covenants in Notes & Their Related Transaction Documents Were Waived for a Limited Purpose

THOMSON REUTERS

Maison Solutions Inc. Delays Financial Report Filing

Consumer Tech News (Dec 1-5): Trump Says He's Back in Elon Musk's Social Circle, U.S. Suspends China MSS Sanctions & More

Benzinga_recent_news

US Reportedly Pauses Salt-Typhoon Sanctions On China, Shelves New Export Controls To Protect Trade Truce

Benzinga_recent_news

MIIT Launches Commercial Trials for Satellite IoT Services

China threat policy questioned amid urgent MI5 warnings

MI5 warned Whitehall China uses LinkedIn to spy on MPs

Press Release: Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results

Press Release: Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

Vodafone and AST SpaceMobile Announce New EU Satellite Constellation and Select Germany for European Sovereign Satellite Operations Centre

Maison Solutions Inc. Shareholders Approve Share Issuance and Bylaw Amendments

Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer

Xilio Therapeutics to Present Phase 2 Data for Vilastobart Highlighting Response Rate in Patients with MSS mCRC and High Plasma Tumor Mutational Burden as a Late-Breaking Presentation at SITC 40th Annual Meeting

New Analysis of 13,560 Patients Demonstrates DecisionDx®-Melanoma Stratifies Risk Across Histological Subtypes; Findings to be Presented at Fall Clinical Dermatology Conference

Maison Solutions Inc. Issues $3M Convertible Note

Maison Solutions Inc. Secures $3 Million Convertible Note Financing

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MSS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MSS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSS\",,,,,undefined,":{"symbol":"MSS","market":"US","secType":"STK","nameCN":"Maison Solutions","latestPrice":0.372,"timestamp":1766599200000,"preClose":0.43,"halted":0,"volume":197953,"hourTrading":{"tag":"盘后","latestPrice":0.3999,"preClose":0.372,"latestTime":"15:38 EST","volume":325,"amount":129.9675,"timestamp":1766608711750},"delay":0,"floatShares":8629700,"shares":25229699,"eps":-0.063302,"marketStatus":"Early Closed","change":-0.058,"latestTime":"12-24 13:00:00 EST","open":0.42,"high":0.421,"low":0.37,"amount":78638.016665,"amplitude":0.118605,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.063302,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766739600000},"marketStatusCode":6,"adr":0,"listingDate":1686801600000,"exchange":"NASDAQ","adjPreClose":0.43,"preHourTrading":{"tag":"盘前","latestPrice":0.43,"preClose":0.43,"latestTime":"09:11 EST","volume":208,"amount":89.55999935999999,"timestamp":1766585478549},"postHourTrading":{"tag":"盘后","latestPrice":0.3999,"preClose":0.372,"latestTime":"15:38 EST","volume":325,"amount":129.9675,"timestamp":1766608711750},"volumeRatio":0.093311},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSS\",,,,,undefined,":{"symbol":"MSS","floatShares":8629700,"roa":"-2.53%","roe":"-9.15%","lyrEps":0.067005,"volumeRatio":0.093311,"shares":25229699,"dividePrice":0,"high":0.421,"amplitude":0.118605,"preClose":0.43,"low":0.37,"week52Low":0.302,"pbRate":"0.93","psRate":"0.08","week52High":3.9599,"institutionHeld":0,"latestPrice":0.372,"eps":-0.063302,"divideRate":0,"volume":197953,"delay":0,"ttmEps":-0.063302,"open":0.42,"prevYearClose":1.22,"prevWeekClose":0.4876,"prevMonthClose":0.4306,"prevQuarterClose":1.14,"fiveDayClose":0.4256,"twentyDayClose":0.4186,"sixtyDayClose":1.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-22","symbol":"MSS","fiscalQuarterEnding":"2025/10","expectedEps":0,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1766379600000,"reportTimeType":"post","actualEps":-0.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MSS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MSS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MSS","date":"2025-12-23","current":-5.876592,"percent":0.423507,"low":-131.978833,"twenty":-16.362173,"median":-9.360692,"eighty":14.726058,"high":171.736597,"avg":-10.189491,"sd":53.976792,"marketCap":13192585},"quantilePoints":[{"date":"2023-10-06","current":95.051104,"twenty":42.433528,"median":42.433528,"eighty":52.957043,"marketCap":165760000},{"date":"2023-10-13","current":53.890581,"twenty":42.433528,"median":52.19324,"eighty":70.694259,"marketCap":93980000},{"date":"2023-10-20","current":85.821811,"twenty":42.433528,"median":55.481838,"eighty":70.694259,"marketCap":149665000},{"date":"2023-10-27","current":82.74538,"twenty":44.046002,"median":56.330509,"eighty":81.726975,"marketCap":144300000},{"date":"2023-11-03","current":84.12447,"twenty":51.089968,"median":63.915503,"eighty":85.482343,"marketCap":146705000},{"date":"2023-11-10","current":96.960613,"twenty":53.551113,"median":69.378819,"eighty":87.328201,"marketCap":169090000},{"date":"2023-11-17","current":98.817079,"twenty":54.208832,"median":80.199368,"eighty":94.520685,"marketCap":172327500},{"date":"2023-11-24","current":140.573349,"twenty":55.481838,"median":84.97314,"eighty":96.960613,"marketCap":245146426},{"date":"2023-12-01","current":163.945785,"twenty":56.330509,"median":86.140063,"eighty":104.492564,"marketCap":285905711},{"date":"2023-12-08","current":163.719965,"twenty":58.240018,"median":88.420865,"eighty":140.573349,"marketCap":285511902},{"date":"2023-12-15","current":171.736597,"twenty":59.40694,"median":91.656421,"eighty":155.816242,"marketCap":299492139},{"date":"2023-12-22","current":25.627315,"twenty":53.890581,"median":88.420865,"eighty":152.316023,"marketCap":33473809},{"date":"2023-12-29","current":20.803349,"twenty":47.270951,"median":87.625236,"eighty":147.980266,"marketCap":27172856},{"date":"2024-01-05","current":17.336124,"twenty":42.433528,"median":86.087021,"eighty":144.841359,"marketCap":22644047},{"date":"2024-01-12","current":13.568909,"twenty":34.099403,"median":84.12447,"eighty":143.192868,"marketCap":17723397},{"date":"2024-01-19","current":11.411692,"twenty":24.572072,"median":77.653357,"eighty":140.573349,"marketCap":14905690},{"date":"2024-01-26","current":12.831747,"twenty":17.788371,"median":69.166652,"eighty":140.573349,"marketCap":16760533},{"date":"2024-02-02","current":13.733225,"twenty":15.074891,"median":59.40694,"eighty":106.508156,"marketCap":17938023},{"date":"2024-02-09","current":16.58238,"twenty":14.125173,"median":55.906174,"eighty":105.447318,"marketCap":21659523},{"date":"2024-02-16","current":25.175067,"twenty":14.548777,"median":53.466246,"eighty":104.492564,"marketCap":32883094},{"date":"2024-02-23","current":21.104847,"twenty":14.726058,"median":42.433528,"eighty":104.32283,"marketCap":27566666},{"date":"2024-03-01","current":23.064583,"twenty":15.013988,"median":42.433528,"eighty":102.667922,"marketCap":30126428},{"date":"2024-03-08","current":23.818328,"twenty":15.316089,"median":36.028989,"eighty":99.506624,"marketCap":31110952},{"date":"2024-03-15","current":19.29586,"twenty":16.341182,"median":28.039296,"eighty":97.331906,"marketCap":25203809},{"date":"2024-03-22","current":-113.246356,"twenty":14.726058,"median":26.833306,"eighty":95.433006,"marketCap":26188333},{"date":"2024-03-28","current":-118.355211,"twenty":13.992212,"median":25.627315,"eighty":93.459846,"marketCap":27369761},{"date":"2024-04-05","current":-107.286018,"twenty":13.539061,"median":24.948944,"eighty":91.953456,"marketCap":24809999},{"date":"2024-04-12","current":-102.177162,"twenty":13.066915,"median":24.270574,"eighty":90.128814,"marketCap":23628571},{"date":"2024-04-19","current":-103.880113,"twenty":11.529276,"median":23.969076,"eighty":89.04676,"marketCap":24022380},{"date":"2024-04-26","current":-93.662397,"twenty":-30.862157,"median":23.667579,"eighty":88.304173,"marketCap":21659523},{"date":"2024-05-03","current":-88.553541,"twenty":-92.12974,"median":23.064583,"eighty":87.710103,"marketCap":20478095},{"date":"2024-05-10","current":-102.177162,"twenty":-99.62273,"median":22.913834,"eighty":86.734132,"marketCap":23628571},{"date":"2024-05-17","current":-103.028636,"twenty":-100.474208,"median":21.858591,"eighty":86.076413,"marketCap":23825475},{"date":"2024-05-24","current":-91.959447,"twenty":-100.474208,"median":20.803349,"eighty":85.906678,"marketCap":21265714},{"date":"2024-05-31","current":-92.81092,"twenty":-100.474208,"median":19.29586,"eighty":85.142875,"marketCap":21462618},{"date":"2024-06-07","current":-97.068302,"twenty":-100.474208,"median":18.391367,"eighty":83.572834,"marketCap":22447142},{"date":"2024-06-14","current":-120.909639,"twenty":-100.474208,"median":17.562248,"eighty":81.726975,"marketCap":27960475},{"date":"2024-06-21","current":-108.137496,"twenty":-102.177162,"median":16.808503,"eighty":77.653357,"marketCap":25006904},{"date":"2024-06-28","current":-123.464072,"twenty":-102.177162,"median":15.979384,"eighty":77.483623,"marketCap":28551190},{"date":"2024-07-05","current":-112.394878,"twenty":-102.177162,"median":14.922634,"eighty":75.658981,"marketCap":25991428},{"date":"2024-07-12","current":-108.988973,"twenty":-103.709818,"median":14.125173,"eighty":69.293952,"marketCap":25203809},{"date":"2024-07-15","current":-110.691923,"twenty":-104.385891,"median":14.100299,"eighty":69.209085,"marketCap":25597618},{"date":"2024-08-02","current":-90.256492,"twenty":-104.217298,"median":14.075425,"eighty":69.124218,"marketCap":20871904},{"date":"2024-08-09","current":-77.484348,"twenty":-103.369227,"median":13.651067,"eighty":68.636233,"marketCap":17918333},{"date":"2024-08-16","current":-5.24654,"twenty":-103.028636,"median":13.49655,"eighty":63.01379,"marketCap":17524523},{"date":"2024-08-23","current":-3.995564,"twenty":-102.773194,"median":13.146812,"eighty":58.706787,"marketCap":13346007},{"date":"2024-08-30","current":-4.22317,"twenty":-102.347457,"median":12.831747,"eighty":57.094313,"marketCap":14106257},{"date":"2024-09-06","current":-4.83448,"twenty":-102.177162,"median":11.607666,"eighty":55.991041,"marketCap":16148159},{"date":"2024-09-13","current":-4.347554,"twenty":-102.177162,"median":11.115471,"eighty":54.845335,"marketCap":14521726},{"date":"2024-09-20","current":-4.715991,"twenty":-102.177162,"median":-3.808162,"eighty":53.720847,"marketCap":15752380},{"date":"2024-09-27","current":-10.100234,"twenty":-102.177162,"median":-3.90838,"eighty":52.278107,"marketCap":25597618},{"date":"2024-10-04","current":-9.478681,"twenty":-102.177162,"median":-3.985012,"eighty":47.270951,"marketCap":24022380},{"date":"2024-10-11","current":-9.711763,"twenty":-101.836571,"median":-4.110575,"eighty":42.433528,"marketCap":24613095},{"date":"2024-10-18","current":-8.235575,"twenty":-101.325685,"median":-4.244392,"eighty":42.433528,"marketCap":20871904},{"date":"2024-10-25","current":-7.847105,"twenty":-100.985094,"median":-4.358165,"eighty":42.433528,"marketCap":19887380},{"date":"2024-10-31","current":-7.110564,"twenty":-100.474208,"median":-4.421241,"eighty":41.484268,"marketCap":18020723},{"date":"2024-11-08","current":-8.157881,"twenty":-100.474208,"median":-4.598091,"eighty":37.35558,"marketCap":20674999},{"date":"2024-11-15","current":-7.614022,"twenty":-100.474208,"median":-4.763445,"eighty":35.546593,"marketCap":19296666},{"date":"2024-11-22","current":-7.610915,"twenty":-100.474208,"median":-4.848628,"eighty":32.682364,"marketCap":19288790},{"date":"2024-11-29","current":-7.304023,"twenty":-100.474208,"median":-5.421621,"eighty":28.94379,"marketCap":18511016},{"date":"2024-12-06","current":-6.992469,"twenty":-99.62273,"median":-5.705759,"eighty":27.134803,"marketCap":17721428},{"date":"2024-12-13","current":-8.080187,"twenty":-99.62273,"median":-6.992469,"eighty":27.134803,"marketCap":20478095},{"date":"2024-12-20","current":-7.310906,"twenty":-99.62273,"median":-7.07094,"eighty":26.833306,"marketCap":21068809},{"date":"2024-12-27","current":-7.925842,"twenty":-98.26037,"median":-7.186705,"eighty":25.868513,"marketCap":22840952},{"date":"2025-01-03","current":-8.472451,"twenty":-97.408893,"median":-7.304023,"eighty":25.627315,"marketCap":24416190},{"date":"2025-01-10","current":-8.814083,"twenty":-97.068302,"median":-7.345923,"eighty":25.446416,"marketCap":25400714},{"date":"2025-01-17","current":-7.242579,"twenty":-97.068302,"median":-7.379232,"eighty":25.114768,"marketCap":20871904},{"date":"2025-01-24","current":-7.720863,"twenty":-96.727712,"median":-7.38094,"eighty":24.994169,"marketCap":22250237},{"date":"2025-01-31","current":-7.648437,"twenty":-95.195057,"median":-7.420176,"eighty":24.81327,"marketCap":22041518},{"date":"2025-02-07","current":-7.857515,"twenty":-94.513875,"median":-7.443095,"eighty":24.511772,"marketCap":22644047},{"date":"2025-02-14","current":-8.609104,"twenty":-94.343579,"median":-7.452707,"eighty":24.240424,"marketCap":24809999},{"date":"2025-02-21","current":-8.745756,"twenty":-93.662397,"median":-7.458634,"eighty":24.119825,"marketCap":25203809},{"date":"2025-02-28","current":-8.13082,"twenty":-93.662397,"median":-7.515884,"eighty":24.119825,"marketCap":23431666},{"date":"2025-03-07","current":-9.292366,"twenty":-92.81092,"median":-7.526106,"eighty":23.818328,"marketCap":26779047},{"date":"2025-03-14","current":-9.22404,"twenty":-92.81092,"median":-7.54099,"eighty":23.818328,"marketCap":26582142},{"date":"2025-03-21","current":-15.798691,"twenty":-91.959447,"median":-7.58421,"eighty":23.667579,"marketCap":20871904},{"date":"2025-03-28","current":-16.842001,"twenty":-91.959447,"median":-7.614022,"eighty":23.51683,"marketCap":22250237},{"date":"2025-04-04","current":-15.351559,"twenty":-91.107969,"median":-7.646769,"eighty":23.064583,"marketCap":20281190},{"date":"2025-04-11","current":-15.351559,"twenty":-91.107969,"median":-7.652869,"eighty":23.064583,"marketCap":20281190},{"date":"2025-04-17","current":-15.05347,"twenty":-90.433599,"median":-7.691717,"eighty":23.064583,"marketCap":19887380},{"date":"2025-04-25","current":-14.475179,"twenty":-90.258195,"median":-7.745137,"eighty":22.943984,"marketCap":19123390},{"date":"2025-05-02","current":-14.680859,"twenty":-89.57531,"median":-7.847105,"eighty":22.431437,"marketCap":19395118},{"date":"2025-05-09","current":-13.042863,"twenty":-88.723836,"median":-7.847105,"eighty":22.190239,"marketCap":17231135},{"date":"2025-05-16","current":-14.345495,"twenty":-88.553541,"median":-7.857515,"eighty":21.677693,"marketCap":18952063},{"date":"2025-05-23","current":-15.05347,"twenty":-85.828817,"median":-7.924799,"eighty":21.195296,"marketCap":19887380},{"date":"2025-05-30","current":-13.123347,"twenty":-83.104091,"median":-7.925842,"eighty":20.923948,"marketCap":17337464},{"date":"2025-06-06","current":-13.266429,"twenty":-80.873221,"median":-8.062494,"eighty":20.803349,"marketCap":17526492},{"date":"2025-06-13","current":-13.23513,"twenty":-78.608296,"median":-8.105504,"eighty":19.898856,"marketCap":17485142},{"date":"2025-06-20","current":-13.424834,"twenty":-77.484348,"median":-8.13082,"eighty":19.23556,"marketCap":17735763},{"date":"2025-06-27","current":-13.041373,"twenty":-77.198252,"median":-8.164983,"eighty":18.903913,"marketCap":17229166},{"date":"2025-07-03","current":-13.442302,"twenty":-76.75889,"median":-8.199147,"eighty":18.481816,"marketCap":17758840},{"date":"2025-07-11","current":-13.413983,"twenty":-76.700987,"median":-8.267472,"eighty":18.150168,"marketCap":17721428},{"date":"2025-07-18","current":-15.05347,"twenty":-64.674697,"median":-8.335799,"eighty":17.697922,"marketCap":19887380},{"date":"2025-07-25","current":-13.649473,"twenty":-16.842001,"median":-8.404125,"eighty":17.275824,"marketCap":18032537},{"date":"2025-08-01","current":-13.002621,"twenty":-16.782383,"median":-8.540778,"eighty":16.944177,"marketCap":17177971},{"date":"2025-08-08","current":-12.670252,"twenty":-16.514104,"median":-8.577728,"eighty":16.341182,"marketCap":16738873},{"date":"2025-08-15","current":14.34762,"twenty":-16.394868,"median":-8.67743,"eighty":15.316089,"marketCap":16776285},{"date":"2025-08-22","current":13.603295,"twenty":-16.33525,"median":-8.546352,"eighty":15.013988,"marketCap":15905966},{"date":"2025-08-29","current":15.034689,"twenty":-16.09678,"median":-8.472451,"eighty":14.981827,"marketCap":17579656},{"date":"2025-09-05","current":15.82785,"twenty":-16.09678,"median":-8.404125,"eighty":15.324337,"marketCap":18507078},{"date":"2025-09-12","current":18.692322,"twenty":-15.947736,"median":-8.335799,"eighty":15.82785,"marketCap":21856428},{"date":"2025-09-19","current":16.503131,"twenty":-15.798691,"median":-8.267472,"eighty":16.503131,"marketCap":19296666},{"date":"2025-09-26","current":-17.61407,"twenty":-16.09678,"median":-8.301635,"eighty":16.307788,"marketCap":18902856},{"date":"2025-10-03","current":-19.448869,"twenty":-16.842001,"median":-8.335799,"eighty":16.034982,"marketCap":20871904},{"date":"2025-10-10","current":-17.368911,"twenty":-17.52233,"median":-8.438288,"eighty":15.89521,"marketCap":18639760},{"date":"2025-10-17","current":-15.025619,"twenty":-17.52233,"median":-8.546352,"eighty":15.82785,"marketCap":16125013},{"date":"2025-10-24","current":-15.133166,"twenty":-17.368911,"median":-8.643267,"eighty":15.627455,"marketCap":16240429},{"date":"2025-10-31","current":-14.38447,"twenty":-17.251023,"median":-8.70174,"eighty":15.376388,"marketCap":15436953},{"date":"2025-11-07","current":-12.556428,"twenty":-16.842001,"median":-8.745756,"eighty":15.329388,"marketCap":13475157},{"date":"2025-11-14","current":-12.100343,"twenty":-16.842001,"median":-8.814083,"eighty":15.324337,"marketCap":12985701},{"date":"2025-11-21","current":-9.467278,"twenty":-16.705013,"median":-8.947463,"eighty":15.074891,"marketCap":10159980},{"date":"2025-11-28","current":-10.123194,"twenty":-16.618975,"median":-8.947463,"eighty":15.042729,"marketCap":10863888},{"date":"2025-12-05","current":-12.274314,"twenty":-16.554624,"median":-9.09021,"eighty":14.996968,"marketCap":13172401},{"date":"2025-12-12","current":-10.95543,"twenty":-16.424677,"median":-9.22404,"eighty":14.895928,"marketCap":11757017},{"date":"2025-12-19","current":-10.520505,"twenty":-16.394868,"median":-9.323293,"eighty":14.790908,"marketCap":11290269},{"date":"2025-12-23","current":-12.293122,"twenty":-16.362173,"median":-9.360692,"eighty":14.726058,"marketCap":13192585}],"updateTime":1766615472073},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MSS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2593745857","title":"Maison Solutions Q2 EPS $(0.23) Down From $(0.01) YoY, Sales $27.625M Miss $29.500M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2593745857","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593745857?lang=en_us&edition=fundamental","pubTime":"2025-12-23 05:07","pubTimestamp":1766437630,"startTime":"0","endTime":"0","summary":"Maison Solutions (NASDAQ:MSS) reported quarterly losses of $(0.23) per share. This is a 2200 percent decrease over losses of $(0.01) per share from the same period last year.  The company reported quarterly sales of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/12/49549409/maison-solutions-q2-eps-0-23-down-from-0-01-yoy-sales-27-625m-miss-29-500m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Maison Solutions Q2 EPS $(0.23) Down From $(0.01) YoY, Sales $27.625M Miss $29.500M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSS"],"gpt_icon":0},{"id":"2592665751","title":"BRIEF-Maison Solutions Inc Enters Consent And Waiver With Investor","url":"https://stock-news.laohu8.com/highlight/detail?id=2592665751","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592665751?lang=en_us&edition=fundamental","pubTime":"2025-12-19 19:22","pubTimestamp":1766143363,"startTime":"0","endTime":"0","summary":"BRIEF-Maison Solutions Inc Enters Consent And Waiver With InvestorDec 19  - Maison Solutions Inc MSS.O:MAISON SOLUTIONS INC - ENTERS CONSENT AND WAIVER WITH INVESTOR - SEC FILINGMAISON SOLUTIONS: UNDER AGREEMENT, SOME RESTRICTIVE COVENANTS IN NOTES & THEIR RELATED TRANSACTION DOCUMENTS WERE WAIVED FOR A LIMITED PURPOSEFurther company coverage: MSS.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XO1DT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSS","BK4113"],"gpt_icon":0},{"id":"2592657701","title":"Maison Solutions Inc - Enters Consent and Waiver With Investor - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2592657701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592657701?lang=en_us&edition=fundamental","pubTime":"2025-12-19 19:10","pubTimestamp":1766142634,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XO1DT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MSS","BK4113"],"gpt_icon":0},{"id":"2592650941","title":"Maison Solutions: Under Agreement, Some Restrictive Covenants in Notes & Their Related Transaction Documents Were Waived for a Limited Purpose","url":"https://stock-news.laohu8.com/highlight/detail?id=2592650941","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592650941?lang=en_us&edition=fundamental","pubTime":"2025-12-19 19:10","pubTimestamp":1766142634,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XO1DT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4113","MSS"],"gpt_icon":0},{"id":"2591684751","title":"Maison Solutions Inc. Delays Financial Report Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2591684751","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591684751?lang=en_us&edition=fundamental","pubTime":"2025-12-13 06:25","pubTimestamp":1765578335,"startTime":"0","endTime":"0","summary":"Maison Solutions Inc. has disclosed a delay in filing its quarterly financial report for the period ended October 31, 2025. The company was unable to timely prepare and finalize the necessary financial information required for its Form 10-Q, but expects to file within the extension period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maison Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL5GhHKN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4113","MSS"],"gpt_icon":0},{"id":"2589870642","title":"Consumer Tech News (Dec 1-5): Trump Says He's Back in Elon Musk's Social Circle, U.S. Suspends China MSS Sanctions & More","url":"https://stock-news.laohu8.com/highlight/detail?id=2589870642","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589870642?lang=en_us&edition=fundamental","pubTime":"2025-12-07 22:46","pubTimestamp":1765118760,"startTime":"0","endTime":"0","summary":"Trump claims he has restored ties with Elon Musk, signaling a thaw in their relationship after earlier conflicts, sparking attention in the tech and political world. Conservative advocacy groups, including Steve Bannon, urge Trump administration to stop Big Tech from using copyrighted content for AI training without permission.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/07/Donald-Trumps-Conversation-With-Elon-Mus.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/07/Donald-Trumps-Conversation-With-Elon-Mus.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/large-cap/25/12/49247787/consumer-tech-news-dec-1-5-trump-says-hes-back-in-elon-musks-social-circle-u-s-suspends-china-mss-sanctions-more","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/large-cap/25/12/49247787/consumer-tech-news-dec-1-5-trump-says-hes-back-in-elon-musks-social-circle-u-s-suspends-china-mss-sanctions-more","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["NVDY","NVD","PSQ","2NVD.UK","QID","NVDS.UK","SQQQ","USJW.SI","TSYW.SI","NVD3.UK","NVD2.UK","NQmain","QLD","AI",".IXIC","MNQmain","SNVD.UK","ACN","F","UFO","TQQQ","TSLA","USAW.SI","MSS","DXYZ","NVDD","3NVD.UK","RIVN"],"gpt_icon":1},{"id":"2588889355","title":"US Reportedly Pauses Salt-Typhoon Sanctions On China, Shelves New Export Controls To Protect Trade Truce","url":"https://stock-news.laohu8.com/highlight/detail?id=2588889355","media":"Benzinga_recent_news","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588889355?lang=en_us&edition=fundamental","pubTime":"2025-12-04 19:47","pubTimestamp":1764848820,"startTime":"0","endTime":"0","summary":"The United States has reportedly decided to suspend the imposition of sanctions on China's Ministry of State Security (MSS) to preserve the trade truce between the two nations.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/04/Usa-And-China-Flags-Painted-On-Cracked-W.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/04/Usa-And-China-Flags-Painted-On-Cracked-W.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/legal/25/12/49204497/us-reportedly-pauses-salt-typhoon-sanctions-on-china-shelves-new-export-controls-to-protect-trade-truce","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/legal/25/12/49204497/us-reportedly-pauses-salt-typhoon-sanctions-on-china-shelves-new-export-controls-to-protect-trade-truce","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU2236285917.USD","LU2286300806.USD","MSS","LU1221951129.SGD","IE00BKVL7J92.USD","LU1162221912.USD","LU0950375773.USD","SG9999002224.SGD","LU1880398471.USD","CSCO","LU1032955483.USD","LU2247934214.USD","SG9999015978.USD","LU2237443382.USD","LU2456880835.USD","SG9999002232.USD","LU1430594728.SGD","IE00BFXG1179.USD","LU1506573853.SGD","LU1066051498.USD","LU1674673691.USD","IE00BSNM7G36.USD","LU1929549753.HKD","BK4550","IE00BVYPNW00.USD","BK4525","BK4579","LU1674673428.USD","LU1221951046.USD","LU0203347892.USD","LU1244550494.USD","SG9999015986.USD","BK4515","LU0889566641.SGD","LU1267930813.SGD","LU2417539215.USD","LU0234570918.USD","LU2506951875.HKD","IE00BZ1G4Q59.USD","LU0792757196.USD","BK4581","LU1585245621.USD","LU1823568750.SGD","LU1046421795.USD","LU0731783394.SGD","BK4585","LU0348723411.USD","LU1778281490.HKD","IE00B1BXHZ80.USD","LU1235294995.USD"],"gpt_icon":0},{"id":"1193182286","title":"MIIT Launches Commercial Trials for Satellite IoT Services","url":"https://stock-news.laohu8.com/highlight/detail?id=1193182286","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193182286?lang=en_us&edition=fundamental","pubTime":"2025-11-28 16:11","pubTimestamp":1764317470,"startTime":"0","endTime":"0","summary":"The Ministry of Industry and Information Technology (MIIT) has issued a notice to organize commercial trials for satellite Internet of Things (IoT) services, with a trial period of two years....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSS","BK4113","BK4170","OSS"],"gpt_icon":0},{"id":"2585246683","title":"China threat policy questioned amid urgent MI5 warnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2585246683","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585246683?lang=en_us&edition=fundamental","pubTime":"2025-11-24 18:57","pubTimestamp":1763981839,"startTime":"0","endTime":"0","summary":"Chinese state-linked operatives are running \"relentless\" influence/ Despite MI5 sounding its most urgent alarm over Chinese intelligence activity in Westminster yet, the UK government has refused to label China a national security threat.According to new MI5 analysis circulated to MPs last week, Chinese state-linked operatives are running “relentless” influence and information-gathering operations across Whitehall,using LinkedIn to target parliamentary researchers, advisers, and economists.Yet, even as the security services ramp up their warnings, the political system around them is pulling them in the other direction.The Crown Prosecution Service  recently collapsed a high-profile spy case after ministers refused to confirm that China meets the legal threshold of a national security threat, a move that stunned intelligence specialists and triggered political backlash.One Commons researcher told the BBC he received a job offer from one of the profiles, written in broken English.“If it ","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2022/12/GettyImages-631967732.jpg-2-1.jpeg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2022/12/GettyImages-631967732.jpg-2-1.jpeg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/china-threat-policy-questioned-amid-urgent-mi5-warnings/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/china-threat-policy-questioned-amid-urgent-mi5-warnings/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["CPS","MSS","BK4124","BK4113"],"gpt_icon":0},{"id":"2584937254","title":"MI5 warned Whitehall China uses LinkedIn to spy on MPs","url":"https://stock-news.laohu8.com/highlight/detail?id=2584937254","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584937254?lang=en_us&edition=fundamental","pubTime":"2025-11-18 20:48","pubTimestamp":1763470113,"startTime":"0","endTime":"0","summary":"Lindsay told MPs that Beijing’s objective was to “collect information and lay the groundwork for long-term relationships” using networking platforms, recruiters and consultants acting covertly.Stay ahead with our three daily briefings delivering all the key market moves, top business and political stories, and incisive analysis straight to your inbox.Security minister Dan Jarvis is expected to update the Commons later today on the government’s response to Chinese espionage activity.China spy prosecution escalatesThe warning lands in the midst of a broader row over the UK’s handling of threats from Beijing, following the collapse of a high-profile prosecution last month.The Crown Prosecution Service dropped charges against two men accused of spying for China after prosecutors were unable to secure government confirmation that Beijing constitutes a national security threat, a legal threshold required for conviction.","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2025/11/GettyImages-2204478580-1.jpg?w=286&h=161&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2025/11/GettyImages-2204478580-1.jpg?w=286&h=161&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/mi5-warned-whitehall-china-uses-linkedin-to-spy-on-mps/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/mi5-warned-whitehall-china-uses-linkedin-to-spy-on-mps/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BK4113","LNKD","MSS"],"gpt_icon":0},{"id":"2583679215","title":"Press Release: Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2583679215","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583679215?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:30","pubTimestamp":1763037000,"startTime":"0","endTime":"0","summary":"Reported late-breaking Phase 2 data at SITC for vilastobart demonstrating a 40% ORR in heavily pretreated patients with MSS mCRC without liver metastases and high plasma tumor mutational burden. Presented Phase 1 data at SITC for efarindodekin alfa showing promising monotherapy anti-tumor activity and generally well-tolerated safety profile in patients with advanced solid tumors. Announced new preclinical data at SITC for masked T cell engager programs supporting best-in-class potential and showing efficient masking, potent anti-tumor activity and broad therapeutic index. Anticipate cash runway into the first quarter of 2027. WALTHAM, Mass., Nov. 13, 2025  -- Xilio Therapeutics, Inc. , a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced pipeline progress and business updates and reported financial results for the third quarter ended September 30, 2025.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORR","MSS","BK4139","XLO","L","TMB","BK4107","LU2487616109.SGD","BK4588","BK4539","SITC","BK4022","BK4585","BK4232","LU0210528500.USD","LENZ","LU0053666078.USD","R","BK4007","BK4231","BK4113","BK4080"],"gpt_icon":0},{"id":"2581628886","title":"Press Release: Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2581628886","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581628886?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:05","pubTimestamp":1762524300,"startTime":"0","endTime":"0","summary":"40% ORR in heavily pre-treated patients with MSS mCRC without liver metastases and with high plasma tumor mutational burden . Estimate 55% of patients with MSS CRC have high plasma TMB, representing a meaningful population with high unmet need. \"These compelling new Phase 2 data for vilastobart in combination with atezolizumab demonstrated a 40% objective response rate in heavily pre-pretreated patients with MSS mCRC without liver metastases and with high plasma TMB, signifying an important advance in our understanding of response to novel immunotherapy in MSS mCRC,\" said Katarina Luptakova, M.D., chief medical officer of Xilio. \"In addition, these data showed a statistically significant correlation between plasma-based TMB and response. We estimate that approximately 55% of patients with MSS CRC have high plasma TMB, representing a meaningful patient population who could ultimately benefit from combination treatment with vilastobart and a substantially greater prevalence of patients w","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4113","BK4552","BK4585","BK4509","XLO","BK4139","SG9999011746.SGD","BK4108","BK4526","BK4080","BK4107","BK4531","BK4232","LU0359202008.SGD","01308","IE0003851619.USD","LENZ","TME","BK1541","BK4565","BK4588","MSS","IE00BYTNYN87.SGD","ORR","LU0210528500.USD","BK4022","IE00B12V2V27.USD","IE0003795394.USD","LU0359201612.USD","IE00BYQNZ168.SGD","LU2487616109.SGD","01698","LU0053666078.USD","BK4535","LU2039709279.SGD","TMB","BK4563","BK4007","LU0456842615.SGD","BK4539","BK4571","SITC","BK4548","BK1103","BK4231","R","L","LU1023057109.AUD"],"gpt_icon":0},{"id":"2581888667","title":"Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2581888667","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581888667?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:01","pubTimestamp":1762524060,"startTime":"0","endTime":"0","summary":"Preclinical data support best-in-class potential of masked T cell engager programs and platform utilizing Xilio’s ATACR and SEECR formats, including efficient masking, potent anti-tumor activity and b","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3183720/0/en/Xilio-Therapeutics-Highlights-Portfolio-of-Differentiated-Masked-Immunotherapies-at-Society-for-Immunotherapy-of-Cancer-SITC-40th-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999011746.SGD","BK4565","MSS","BK1103","BK4563","01698","LU1169589451.USD","LU2039709279.SGD","PD","BK4113","BK4535","IE0003795394.USD","BK4007","BK4548","01308","BK4539","LENZ","IE00BYQNZ168.SGD","BK4509","TME","BK4526","LU1023057109.AUD","IE00BYTNYN87.SGD","LU1169590202.USD","BK4080","BK4552","LU0456842615.SGD","LU0359202008.SGD","SITC","IE00B12V2V27.USD","BK4139","IE0003851619.USD","LU0359201612.USD","BK1541","BK4231","BK4571","BK4531","BK4023","BK4108"],"gpt_icon":0},{"id":"2581707968","title":"Vodafone and AST SpaceMobile Announce New EU Satellite Constellation and Select Germany for European Sovereign Satellite Operations Centre","url":"https://stock-news.laohu8.com/highlight/detail?id=2581707968","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581707968?lang=en_us&edition=fundamental","pubTime":"2025-11-07 15:00","pubTimestamp":1762498800,"startTime":"0","endTime":"0","summary":"Vodafone and AST SpaceMobile select Germany for Satellite Operations Centre to further strengthen Europe’s digital sovereignty.Move follows establishment of Vodafone and AST SpaceMobile Luxembourg-hea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"2d35f1d37c4abb786e455c66ddb35513","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3183375/0/en/Vodafone-and-AST-SpaceMobile-Announce-New-EU-Satellite-Constellation-and-Select-Germany-for-European-Sovereign-Satellite-Operations-Centre.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4113","SLCT","CSTA.U","BK4152","BK4089","TTC","ASTS","LU1543694498.USD","MSS","LU1165135440.EUR","BK4156"],"gpt_icon":1},{"id":"2580778758","title":"Maison Solutions Inc. Shareholders Approve Share Issuance and Bylaw Amendments","url":"https://stock-news.laohu8.com/highlight/detail?id=2580778758","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580778758?lang=en_us&edition=fundamental","pubTime":"2025-11-04 19:09","pubTimestamp":1762254572,"startTime":"0","endTime":"0","summary":"Maison Solutions Inc. has announced that holders of a majority of its outstanding voting securities have approved key corporate actions, including amendments to its Certificate of Incorporation and Amended and Restated By-Laws, as well as a share issuance. These decisions were formalized by written consent dated October 19, 2025, and will become effective twenty days after the Information Statement is made available to stockholders of record as of November 6, 2025. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maison Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nNDL4qyVFN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSS","BK4113"],"gpt_icon":0},{"id":"2579546872","title":"Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2579546872","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579546872?lang=en_us&edition=fundamental","pubTime":"2025-10-31 19:00","pubTimestamp":1761908400,"startTime":"0","endTime":"0","summary":"Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based onprevious alignment with FDA Patients randomized to either 10 or 20 mg/kg of muzastotug, i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/31/3178218/0/en/Adagene-Announces-First-Patient-Dosed-in-Randomized-Dose-Optimization-Cohort-of-the-Phase-2-Study-of-Muzastotug-ADG126-in-Combination-with-KEYTRUDA-pembrolizumab-in-Microsatellite-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1035773651.USD","LU1941712264.USD","LU0965509010.AUD","LU1983299246.USD","BK4097","LU1929549753.HKD","SG9999014542.SGD","LU0266512127.USD","SG9999001176.USD","SG9999002224.SGD","LU0203347892.USD","LU1934455277.USD","BK4588","LU1061106388.HKD","LU1974910355.USD","LU1989772840.SGD","BK4139","MSS","LU1989772923.USD","ADAG","LU1291159041.SGD","SG9999014559.SGD","LU1430594728.SGD","OS","ORR","SOC","SG9999015341.SGD","MRK","LU0058720904.USD","SG9999002232.USD","IE00BJT1NW94.SGD","SG9999001176.SGD","CRC","LU1934455194.USD","BK4559","IE00BN8TJ469.HKD","LU1934455863.HKD","IE00B4R5TH58.HKD","LU0265550359.USD","LU0211331839.USD","IE00BLSP4239.USD","PFS","LU0106261372.USD","IE0009355771.USD","LU1066053197.SGD","LU1066051811.HKD","SG9999014567.USD","BK4550","LU0238689110.USD","SGXZ57979304.SGD"],"gpt_icon":0},{"id":"2579142130","title":"Xilio Therapeutics to Present Phase 2 Data for Vilastobart Highlighting Response Rate in Patients with MSS mCRC and High Plasma Tumor Mutational Burden as a Late-Breaking Presentation at SITC 40th Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2579142130","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579142130?lang=en_us&edition=fundamental","pubTime":"2025-10-30 21:01","pubTimestamp":1761829260,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., Oct.  30, 2025  (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/30/3177502/0/en/Xilio-Therapeutics-to-Present-Phase-2-Data-for-Vilastobart-Highlighting-Response-Rate-in-Patients-with-MSS-mCRC-and-High-Plasma-Tumor-Mutational-Burden-as-a-Late-Breaking-Presentat.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1541","01308","BK4007","SITC","BK4080","MSS","IE00B12V2V27.USD","IE00BYQNZ168.SGD","SG9999011746.SGD","BK4113","IE00BYTNYN87.SGD","LENZ","BK1103","BK4231","BK4139","BK4539"],"gpt_icon":0},{"id":"2577259366","title":"New Analysis of 13,560 Patients Demonstrates DecisionDx®-Melanoma Stratifies Risk Across Histological Subtypes; Findings to be Presented at Fall Clinical Dermatology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2577259366","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577259366?lang=en_us&edition=fundamental","pubTime":"2025-10-24 16:05","pubTimestamp":1761293100,"startTime":"0","endTime":"0","summary":"This new histological subtype data confirms DecisionDx-Melanoma’s clinical value across the spectrum of melanoma Castle Biosciences will also present validation data on its atopic dermatitis pipeline ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/24/3172651/0/en/New-Analysis-of-13-560-Patients-Demonstrates-DecisionDx-Melanoma-Stratifies-Risk-Across-Histological-Subtypes-Findings-to-be-Presented-at-Fall-Clinical-Dermatology-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","BK4113","BK4139","MSS","BK4207","BK4135","BK4132","AD","SLN","CM","BK4546","BK4161","DM"],"gpt_icon":0},{"id":"2577170793","title":"Maison Solutions Inc. Issues $3M Convertible Note","url":"https://stock-news.laohu8.com/highlight/detail?id=2577170793","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577170793?lang=en_us&edition=fundamental","pubTime":"2025-10-23 05:47","pubTimestamp":1761169661,"startTime":"0","endTime":"0","summary":"Maison Solutions Inc. Class A ( ($MSS) ) just unveiled an announcement. On October 22, 2025, Maison Solutions Inc. issued an additional senior unse...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/maison-solutions-inc-issues-3m-convertible-note?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/maison-solutions-inc-issues-3m-convertible-note?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MSS","LU1894683348.USD","SG9999002224.SGD","LU0683600562.USD","BK4512","MMM","SG9999002232.USD","BK4533","BK4206","BK4588","BK4113","BK4534","LU1093756168.USD","LU0787776722.HKD","BK4585","LU1093756325.SGD","LU1894683264.USD"],"gpt_icon":0},{"id":"2577312243","title":"Maison Solutions Inc. Secures $3 Million Convertible Note Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2577312243","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577312243?lang=en_us&edition=fundamental","pubTime":"2025-10-23 05:30","pubTimestamp":1761168615,"startTime":"0","endTime":"0","summary":"Maison Solutions Inc. has entered into a new financing agreement, issuing an additional senior unsecured convertible promissory note with a principal amount of $3 million to an existing investor under a previously established Securities Purchase Agreement. The note, which matures on October 22, 2027, carries an annual interest rate of 5.25%, with the potential to increase to 18% in the event of default. The company received $2,745,000 in proceeds from the note issuance, which will be used for working capital. Maison Solutions retains the option to redeem the note early and may pay accrued interest in cash or in shares of its Class A common stock. The transaction was conducted as a private placement under exemptions from SEC registration.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nNDL8ytk6g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSS","BK4113"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":58,"code":"91000000","status":"200"}]}}